Saturday 23 September 2017
Contact US    |    Archive
PR
10 days ago

FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over

LONDON, Sept. 13, 2017 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the

Read on the original site


Hashtags:   

FDA

 | 

Advisory

 | 

Committee

 | 

votes

 | 

unanimously

 | 

for

 | 

Shingrix

 | 

the

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries